{
    "url_original": "https://www.wsj.com/articles/pfizer-biontech-covid-19-vaccine-for-young-children-to-be-reviewed-by-fda-advisers-11635240602?mod=business_lead_pos1",
    "url": "pfizer-biontech-covid-19-vaccine-for-young-children-to-be-reviewed-by-fda-advisers-11635240602",
    "title": "Pfizer-BioNTech Covid-19 Vaccine for Young Children to Be Reviewed by FDA Advisers",
    "sub_head": "Vaccine experts are expected to give a recommendation on whether the FDA should broaden use of the shot to children ages 5 to 11 years",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-10-26 05:30:00",
    "body": "Experts advising the Food and Drug Administration are scheduled to meet Tuesday to consider endorsing the Covid-19 vaccine from  Pfizer Inc.  and  BioNTech SE  for use in young children.<br />Their positive recommendation would likely soon lead to an expansion of the U.S. vaccination campaign to millions of young children."
}